CUE

Cue Biopharma, Inc. - Common Stock (CUE)

About Cue Biopharma, Inc. - Common Stock (CUE)

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in advancing a portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its pipeline includes CUE-221, a novel anti-IgE antibody with a dual mechanism of action, and CUE-401, designed to regulate inflammation and drive Treg-mediated tolerance. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Details

Daily high

$41.50

Daily low

$23.80

Price at open

$38.50

52 Week High

$45.50

52 Week Low

$4.97

Market cap

269.1M

Dividend yield

Volume

3.5M

Avg. volume

167,409

P/E ratio

-1.37

Cue Biopharma, Inc. - Common Stock News